{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:41:29Z","timestamp":1785300089151,"version":"3.55.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Mucosal healing is a treatment target for patients with ulcerative colitis. However, the relevance of proactive treatment for residual inflammation limited to the distal colon is unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>Patients with ulcerative colitis who had extensive colitis in clinical remission and underwent colonoscopy were retrospectively enrolled and followed up for 2 years. Patients with complete endoscopic remission (CER; Mayo endoscopic subscore [MES] of 0) and those with short-segment distal inflammation (SS; active inflammation only in the sigmoid colon and\/or rectum with a proximal MES of 0) were compared for the incidence of minor (only symptomatic) and major (need for induction treatments or hospitalization) relapses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 91 patients with CER and 54 patients with SS were identified and 63 relapses (47 minor and 16 major) were analyzed. Univariate analysis showed that minor relapses were significantly more frequent in the SS group than in the CER group (hazard ratio [HR], 2.22; 95% confidence interval [CI], 1.25-3.97), but major relapses were not more frequent in the SS group than in the CER group (HR, 1.78; 95% CI, 0.65-4.83). Multivariable analysis showed that SS was the only risk factor significantly associated with minor relapse (HR, 2.38; 95% CI, 1.31-4.36). When the SS group was stratified by MES of 1 vs 2\/3, minor relapses were significantly more frequent in the subgroup with MES of 2\/3 than in the CER group, whereas the incidence of major relapse remained similar.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Residual short-segment distal inflammation is not a risk factor for major relapses as long as endoscopic remission is achieved in the proximal colon. Therefore, reactive but not proactive treatment may be appropriate for such lesions.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ibd\/izab062","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:03:12Z","timestamp":1618362192000},"page":"200-207","source":"Crossref","is-referenced-by-count":9,"title":["Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis"],"prefix":"10.1093","volume":"28","author":[{"given":"Kunio","family":"Asonuma","sequence":"first","affiliation":[{"name":"Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-4234","authenticated-orcid":false,"given":"Taku","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Nakano","sequence":"additional","affiliation":[{"name":"Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"},{"name":"Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Sagami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kiyohara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Matsubayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Morikubo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Miyatani","sequence":"additional","affiliation":[{"name":"Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Okabayashi","sequence":"additional","affiliation":[{"name":"Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"},{"name":"Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine, Kyoto University , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Section of Clinical Epidemiology, Department of Community Medicine, Graduate School of Medicine, Kyoto University , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Kuroki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Showa University Fujigaoka Hospital , Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Hibi","sequence":"additional","affiliation":[{"name":"Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka","year":"2018","journal-title":"J Gastroenterol."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/ibd.21838","article-title":"Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study","volume":"18","author":"Meucci","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","article-title":"Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis","volume":"141","author":"Colombel","year":"2011","journal-title":"Gastroenterology."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ecco-jcc\/jjv158","article-title":"Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs 1): a longitudinal cohort study","volume":"10","author":"Barreiro-de Acosta","year":"2016","journal-title":"J Crohns Colitis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3109\/00365521.2016.1150503","article-title":"Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission","volume":"51","author":"Kim","year":"2016","journal-title":"Scand J Gastroenterol."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ecco-jcc\/jjv180","article-title":"Mucosal healing in ulcerative colitis\u2014when zero is better","volume":"10","author":"Carvalho","year":"2016","journal-title":"J Crohns Colitis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/gutjnl-2014-308839","article-title":"An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis","volume":"64","author":"Manginot","year":"2015","journal-title":"Gut."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19(Suppl A)","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/apt.13408","article-title":"Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials","volume":"42","author":"Jairath","year":"2015","journal-title":"Aliment Pharmacol Ther."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/BF02233941","article-title":"Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets","volume":"11","author":"Wright","year":"1966","journal-title":"Am J Dig Dis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2010.12.028","article-title":"Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis","volume":"9","author":"Ardizzone","year":"2011","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Fr\u00f8slie","year":"2007","journal-title":"Gastroenterology."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/ibd\/izy300","article-title":"Efficacy of therapeutic intervention for patients with an ulcerative colitis Mayo endoscopic score of 1","volume":"25","author":"Fukuda","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","article-title":"Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)","volume":"61","author":"Travis","year":"2012","journal-title":"Gut."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5375.89","article-title":"Variation between observers in describing mucosal appearances in proctocolitis","volume":"1","author":"Baron","year":"1964","journal-title":"Br Med J."},{"key":"2023032820404724700_","first-page":"393","article-title":"The value of rectal biopsy in the diagnosis of ulcerative colitis","volume":"30","author":"Matts","year":"1961","journal-title":"Q J Med."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5217\/ir.2018.16.2.168","article-title":"Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries","volume":"16","author":"Kobayashi","year":"2018","journal-title":"Intest Res."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","article-title":"The pattern and outcome of acute severe colitis","volume":"4","author":"Dinesen","year":"2010","journal-title":"J Crohns Colitis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.gastro.2006.11.015","article-title":"Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years","volume":"132","author":"Hoie","year":"2007","journal-title":"Gastroenterology."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ecco-jcc\/jjw116","article-title":"Predicting outcomes to optimize disease management in inflammatory bowel diseases","volume":"10","author":"Torres","year":"2016","journal-title":"J Crohns Colitis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.13948","article-title":"Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus","volume":"45","author":"Vuitton","year":"2017","journal-title":"Aliment Pharmacol Ther."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00384-013-1817-3","article-title":"Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy","volume":"29","author":"Yamamoto","year":"2014","journal-title":"Int J Colorectal Dis."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/MEG.0000000000000461","article-title":"Clinical application of faecal calprotectin in ulcerative colitis patients","volume":"27","author":"Scaioli","year":"2015","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2023032820404724700_","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.cgh.2019.07.054","article-title":"Significance of conducting 2 types of fecal tests in patients with ulcerative colitis","volume":"18","author":"Naganuma","year":"2020","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/28\/2\/200\/49680139\/izab062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/28\/2\/200\/49680139\/izab062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T02:01:53Z","timestamp":1698890513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/28\/2\/200\/6224886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4,13]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izab062","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,4,13]]}}}